Invivogen
Menu

InvivoGen's product citations

Citations

InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).

Citations search

You can search by ‘Product Name’ or ‘Year’.

Find a citation by product name
Enter a year of publication
Product Citation Year Journal Authors Page
NATE™ - Transfection & Transduction Enhancer EEF2-inactivating toxins engage the NLRP1 inflammasome and promote epithelial... 2023 J Exp Med. Pinilla M. et al. DOI: 10.1084/jem.20230104
Pan-Caspase inhibitor - Z-VAD-FMK EEF2-inactivating toxins engage the NLRP1 inflammasome and promote epithelial... 2023 J Exp Med. Pinilla M. et al. DOI: 10.1084/jem.20230104
NLRP 1 EEF2-inactivating toxins engage the NLRP1 inflammasome and promote epithelial... 2023 J Exp Med. Pinilla M. et al. DOI: 10.1084/jem.20230104
A549-ASC-GFP Reporter Cells for NLRP1 studies EEF2-inactivating toxins engage the NLRP1 inflammasome and promote epithelial... 2023 J Exp Med. Pinilla M. et al. DOI: 10.1084/jem.20230104
NLRP1 Inflammasome Inducer – Val-boroPro EEF2-inactivating toxins engage the NLRP1 inflammasome and promote epithelial... 2023 J Exp Med. Pinilla M. et al. DOI: 10.1084/jem.20230104
A549-ASC-GFP-NLRP1 Reporter Cells for COVID-19 Studies EEF2-inactivating toxins engage the NLRP1 inflammasome and promote epithelial... 2023 J Exp Med. Pinilla M. et al. DOI: 10.1084/jem.20230104
Caspase-8 inhibitor - Z-IETD-FMK EEF2-inactivating toxins engage the NLRP1 inflammasome and promote epithelial... 2023 J Exp Med. Pinilla M. et al. DOI: 10.1084/jem.20230104
ODN 2395 - TLR9 ligand Inactive disease in patients with lupus is linked to autoantibodies to type I... 2023 Cell Rep Med. Bradford H.F. et al. DOI: 10.1016/j.xcrm.2022.100894
Zeocin® Inactive disease in patients with lupus is linked to autoantibodies to type I... 2023 Cell Rep Med. Bradford H.F. et al. DOI: 10.1016/j.xcrm.2022.100894
QUANTI-Blue™ Inactive disease in patients with lupus is linked to autoantibodies to type I... 2023 Cell Rep Med. Bradford H.F. et al. DOI: 10.1016/j.xcrm.2022.100894
Blasticidin Inactive disease in patients with lupus is linked to autoantibodies to type I... 2023 Cell Rep Med. Bradford H.F. et al. DOI: 10.1016/j.xcrm.2022.100894
IFN-α/β Reporter HEK 293 Cells Inactive disease in patients with lupus is linked to autoantibodies to type I... 2023 Cell Rep Med. Bradford H.F. et al. DOI: 10.1016/j.xcrm.2022.100894
LPS-EB (LPS from E. coli O111:B4) Inflammatory Cytokine-Induced HIF-1 Activation Promotes Epithelial-Mesenchyma... 2023 Biomedicines Hashimoto Y. et al. DOI: 10.3390/biomedicines11010210
LPS-EB (LPS from E. coli O111:B4) Protein folding stress potentiates NLRP1 and CARD8 inflammasome activation. 2023 Cell Rep. Orth-He E.L. et al. DOI: 10.1016/j.celrep.2022.111965
LPS-EB VacciGrade™ Inflammation Regulation by Bacterial Molecular Patterns. 2023 Biomedicines Guryanova S.V & Kataeva A. DOI: 10.3390/biomedicines11010183
AddaVax™ Evaluation of Pre-Pandemic Trivalent COBRA HA Vaccine in Mice Pre-Immune to H... 2023 Viruses Ge P. & Ross T.M. DOI: 10.3390/v15010203
R848 (Resiquimod) Effects of Magnetic Nanoparticles on the Functional Activity of Human Monocyt... 2023 Int J Mol Sci. Donini M. et al. DOI: 10.3390/ijms24021358
LPS-EB (LPS from E. coli O111:B4) Effects of Magnetic Nanoparticles on the Functional Activity of Human Monocyt... 2023 Int J Mol Sci. Donini M. et al. DOI: 10.3390/ijms24021358
AddaVax™ Multi-Influenza HA Subtype Protection of Ferrets Vaccinated with an N1 COBRA-... 2023 Viruses Skarlupka A.L. et al. DOI: 10.3390/v15010184
Bafilomycin A1 Jatrophane Diterpenoids from Euphorbia peplus Linn. as Activators of Autophag... 2023 Int J Mol Sci. Yan Y. et al. DOI: 10.3390/ijms24021088

Pages

Customer Service
& Technical Support
Contact us
Shopping cart is empty